Radiosurgery for Cavernous Malformations and Other Vascular Diseases

First author
Patients
FU length
Lesion location
Clinical presentation
Annual bleeding risk
Comment
Robinson [7] (1991)
66 patients
26 months
Supratentorial: 55 patients
Seizures: 34 patients
0.7 % per lesion
– HRG common in female and in infratentorial lesions
Deep: 4 patients
Focal deficit: 30 patients
 
Cerebellar: 9 patients
HRG: 6 patients
 
Brainstem: 8 patients
Incidental: 9 patients
 
Zabramski [4] (1994)
31 patients
2.2 years
Supratentorial: 92 %
Symptomatic: 61 %
HRG + symptom: 6 %
– Developed new cavernoma: 29 %
Multi: 84 %
Infratentorial: 8 %
Incidental: 39 %
HRG overall: 13 %
Aiba [22] (1995)
110 patients
4.71 years
Supratentorial: 65 %
HRG: 62 patients
Re-HRG: 22.9 % per lesion
– Younger and female patients had higher HRG risk
Deep: 11 %
Seizures: 25 patients
 
Brainstem: 18 %
Incidental: 23 patients
 
Kondziolka [23] (1995)
122 patients
34 months
BG/thalamus: 17 %
HRG = 1: 41 %
Total: 2.6 %
– No influence on location, sex, and number on HRG risk
Multi: 20 %
Brainstem: 35 %
HRG > 1: 9 %
No HRG: 0.6 %
  
Seizures: 23 %
Previous HRG: 4.5 %
Porter [2] (1997)
173 patients
46 months
Superficial: 109 patients
HRG: 25.4 %
4.2 % annual rate
– Significantly greater
Multi: 17.9 %
Deep: 64 patients
Seizure: 35.8 %
10.6 % deep location
Bleed rate for deep
  
Neurological deficit: 20.2 %
 
~37 % recovered from
  
Incidental: 12.1 %
 
new deficits
Labauge [11] (2000)
40 patients
3.2 years
Supratentorial: 176
HRG: 19 patients
11 % per patient
– 1/3 bleeds, symptomatic
Multi: 93 %
Cerebellar: 30
Seizures: 12 patients
2.5 % per lesion
– 27.5 % of patients develop new lesions
 
Brainstem: 26
Focal signs: 4 patients
  
Kupersmith [24] (2011)
37 patients
4.9 years
– 12 midbrain
HRG: 73 %
2.5 % per patient
– Young patient with lesion of >10 mm had higher risk of HRG
 
– 18 pons
Mass effect only: 22 %
5.1 % rebleeding risk
 
– 7 medulla
Asymptomatic: 5 %
 
Al-Holou [10] (2012)
92 patients
3.5 years
Supratentorial: 75 patients
Acute symptoms: 17 patients
HRG: 1.6 %/year
– Brainstem location
Multi: 30 %
Infratentorial: 1 patient
Chronic symptoms: 5 patients
Re-HRG: 8 %/year
and age increased
  
Incidental: 34
0.2 % if incidental
bleed rate
Salmon [25] (2012)
139 patients
5 years
Lobar: 67 %
Incidental: 47 %
HRG: 2.4 %/year
– Risk declines over
Multi: 17 %
Brainstem: 14 %
Seizure: 25 %
Re-HRG: 29.5 %/year
5 years and is higher
 
Cerebellum: 13 %
HRG: 12 %
HRG year 1: 19.8 %
for women
 
Deep structures: 6 %
Neurological deficit: 15 %
HRG year 5: 5 %
 
HRG hemorrhage, ARE adverse radiation effect, BG basal ganglia
In older patients or patients with low-risk lesions which are difficult to reach surgically, observation with periodic imaging may be appropriate. When patients present with recurrent hemorrhage, progressive neurological deterioration, or intractable epilepsy, then treatment in the form of surgery or radiosurgery should be considered. The management options for a patient with a cavernous malformation must be based on age, symptoms, hemorrhage risk, and location, especially as it relates to surgical accessibility. Resection clearly provides immediate advantages for accessible lesions and complete resection is achieved in 91 % (62 % bleed rate in partially resected lesions) [26]. However, surgery on average has a 45 % postoperative and 15 % long-term morbidity [26]. These results can be much higher when resection of deep-seated lesions is conducted (Table 50.2) [2733]. For younger patients with more accessible lesions, the removal of lesions may help control epilepsy, improve neurological deficits, and prevent any subsequent hemorrhage. Radiosurgery is a minimally invasive option for patients presenting with recurrent hemorrhages from deep-seated cavernous malformations.
Table 50.2
Summary of reports on resection of deep-seated cavernous malformations
First author
Patients
Location
Presentation
Immediate postoperative outcome
Long-term outcome
Steinberg [27] (2000)
56 patients
Brainstem: 42
HRG: Average of 2.1
16 % improved
43 % improved
Thalamus: 5
55 % stable
52 % stable
Basal ganglia: 10
29 % worse
5 % worse
 
No death
4 patients had re-HRG
Mathiesen [28] (2003)
68 patients
Basal ganglia: 11
Varied with location
25/29 complete resection
Re-HRG: 4 partial resections
Thalamus: 12
HRG 1 or 2: 68 patients
69 % neuro-decline
20 patients improved
Mesencephalon: 5
 
Only 2 (5 %) permanent
(10 patients intact)
Pons: 31
   
4 stable, 5 worse
Medulla: 5
   
1 died of rebleed
Wang [29] (2003)
137 patients
Midbrain: 29
HRG = 1: 45 patients
131/137 total resection
Re-HRG: 3 partial resections
Pons: 85
HRG > 1: 58 patients
72.3 % stable or improved
Death: 1
Medulla: 19
HRG 3 or more: 34 patients
27.7 % new deficits
7.8 % living dependently
Cerebellar peduncle: 8
60 % annual rebleeding
   
Ferroli [30] (2005)
52 patients
Medulla: 7
HRG = 1: 32 patients
4 repeat surgeries
19 % permanent deficits
Pontomedullary: 3
HRG > 1: 18 patients
29 patients stable
Pons: 31
No HRG: 2 patients
23 patients worse
Pontomesencephalic: 3
HRG: 3.8 % annual risk
1 death
Midbrain: 6
Re-HRG: 34.7 % annual
 
Hauck [31] (2009)
44 patients
Pons: 25
HRG = 1: 20 patients
Improved: 30 %
Residual: 1
Midbrain: 11
HRG > 1: 23 patients
Stable: 59 %
Re-HRG: 2 patients
Medulla: 8
 
Worse: 11 %
Revisions: 8 patients
Abla [32] (2011)
260 patients
Pons: 112
HRG: 252 patients
New deficits: 53 %
Death: 3
Medulla: 29
New deficits: 7 patients
Residual lesion: 29
New deficit: 36 %
Midbrain: 49
 
Re-HRG: 7.7
Improved: 45 %
Pontomedullary: 40
 
Died: 2
Re-HRG: 2.0 %
Pontomesencephalic: 31
     
Pandley [33] (2012)
176 patients
Pons: 94
HRG = 1: 70 patients
Second operation: 17 patients
Death: 3
20 pediatric
Midbrain: 28
HRG > 1: 102 patients
New deficit: 31.3 %
Improved: 61.8 %
Medulla: 14
Seizure: 4 patients
Improved: 19.9
Stable: 25.9 %
BG/thalamus: 43
   
Re-HRG: 5 patients
HRG hemorrhage, ARE adverse radiation effect, BG basal ganglia

The Role of Radiosurgery

The successful management of cerebral AVMs with stereotactic radiosurgery prompted the exploration of its role in the management of cavernous malformations. The benefits of radiosurgery for cavernous malformations are difficult to assess because of its unclear natural history and the lack of an imaging technique that can document a “cure.” The role of radiosurgery in this disease is still considered controversial by many physicians. However, the lack of options for surgically inaccessible cavernous malformations has made radiosurgery a possible alternative to conservative management for lesions with a high risk of symptomatic bleeding (Table 50.3) [17, 3440].
Table 50.3
Summary of some recent Gamma Knife radiosurgical series of cavernous malformations
First author
Patients/FU
Location
Presentation
Dose/volume
Outcome
Morbidity
Karlsson [34] (1998)
22 patients
Cortical: 8
HRG: 16 patients
Margin: 18 Gy (9–35)
Post-GK HRG rate: 8 %/year
ARE: 6 patients
Deep cerebral: 7
Epilepsy: 6 patients
 
– Years 1–2: 10 %
– 5 symptoms
GK
6.9 years
Brainstem: 6
Prior resection: 1 patient
 
– Years 3–4: 12 %
Onset 16 months
Cerebellum: 1
   
– Years 5–6: 5 %
 
     
– Years 7–8: 7 %
 
Hasegawa [17] (2002)
82 patients
Supratentorial: 16
HRG: 82 patients (1–7 bleeds)
Margin: 16.2 Gy (12–20)
HRG: 12.3 % first 2 years
ARE: 11 patients
Deep: 13
HRG rate: 33.9 %/year
 
HRG: 0.76 % years 2–12
None after 1992
GK
4.89 years
Brainstem: 52
Prior surgery: 20 patients
Vol.: 1.85 cm3 (0.12–6.98)
   
Liu [35] (2005)
125 patients
Brainstem: 49
HRG: 112 patients
Margin: 12.1 Gy (9–20)
HRG rate: 6.5 %/year
ARE: 13.1 %
BG/thalamus: 14
HRG >1: 45 patients
 
HRG: 10.3 % first 2 years
Symptoms: 2.5 %
GK
5.4 years
Cortical: 39
HRG rate: 29.2 %/year
Vol.: 3.12 cm3 (.032–25.9)
HRG: 3.3 % after year 2
 
Cerebellum: 10
Seizures: 28 patients
     
Kim [36] (2005)
42 patients
Cortical: 21
HRG: 26.6 %
Margin: 14.55 Gy (10–25)
Seizure cessation: 75 %
Edema: 5 patients
Brainstem: 6
Seizures: 28.6 %
 
– Mean of 31.3 months
– Symptoms: 5 patients
GK
29.6 months
Basal ganglia: 5
Neurological deficit: 45.2 %
 
HRG: 1
– Recovered: 5 patients
Liscak [37] (2005)
112 patients
Brainstem: 33
HRG in 59 patients
Margin: 16 Gy (9–36)
HRG rate: 1.6 %/year
Edema: 30 patients
Cortical: 54
Seizures in 40 patients
Vol.: 0.9 cm3 (0.06–12.5)
– 2 deaths from HRG
– Symptoms: 17 patients
GK
48 months
BG/thalamus: 17
Neurological deficit: 51 patients
 
Neurological deficits: 33 % improved
– Recovered: 16 patients
Cerebellum: 8
7 patients prior partial resection
     
Nagy [38] (2010)
113 patients
Brainstem: 79
HRG high risk >1: 41 patients
Margin: 12–15 Gy (10–20)
High risk <2 years: 15 %/year
ARE: 6 symptoms
BG/thalamus: 39
HRG low risk <1: 54 patients
Vol.: 0.33–0.83 cm3
High risk >2 years: 2.4 %/year
 
GK
48 months
 
Neurological deficit high risk: 72 %
 
Low risk <2 years: 5.1 %/year
 
 
Neurological deficit low risk: 43 %
 
Low risk >2 years: 1.3 %/year
 
 
HRG pre GK: 30.5 %/year
     
Lunsford [39] (2010)
103 patients
Brainstem: 66
HRG >1: 103 patients
Margin: 16 Gy (12–20)
HRG <2 years: 10.8 %/year
ARE: 19 patients
BG/thalamus: 27
HRG pre GK: 32.5 %/year
Vol.: 1.31 cm3
HRG > 2 years: 1 %/year
Symptoms: 12 patients
GK
67.8 months
Deep lobar: 10
Seizures: 8 patients
 
75 % seizure cessation
 
Lee [40] (2012)
49 patients
Pons: 34
HRG >1: 49 patients

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jun 2, 2017 | Posted by in GENERAL RADIOLOGY | Comments Off on Radiosurgery for Cavernous Malformations and Other Vascular Diseases

Full access? Get Clinical Tree

Get Clinical Tree app for offline access